SCHEMBL3389935

SCHEMBL3389935

O=C(NCC=Cc1cccc([S+]([O-])CC2CCCCC2)c1)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
HDAC6 Q9UBN7 5/20 0.38
MLYCD O95822 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TLR4 O00206 1/20 0.32
TLR2 O60603 1/20 0.32
ATM Q13315 1/20 0.32
HDAC1 Q13547 3/20 0.32
HDAC3 O15379 2/20 0.32
HDAC4 P56524 2/20 0.32
NPC1 O15118 1/20 0.32
EPHX2 P34913 2/20 0.32
POLB P06746 1/20 0.31
EPHX1 P07099 1/20 0.31
OPRD1 P41143 1/20 0.31
OPRK1 P41145 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3389932 1.00 ALDH1A1 (0.39) ALDH1A1HDAC6MLYCDMEN1KMT2A
SCHEMBL3385937 0.99 ALDH1A1 (0.37) ALDH1A1HDAC6MLYCDMEN1KMT2A
SCHEMBL3385943 0.99 ALDH1A1 (0.37) ALDH1A1HDAC6MLYCDMEN1KMT2A
SCHEMBL13400302 0.81 EPHX1 (0.34) ALDH1A1TLR4TLR2EPHX1
SCHEMBL3388478 0.78 TLR4 (0.37) ALDH1A1TLR4TLR2
SCHEMBL3388474 0.78 TLR4 (0.37) ALDH1A1TLR4TLR2
SCHEMBL3388480 0.78 ALDH1A1 (0.33) ALDH1A1
SCHEMBL3388475 0.78 ALDH1A1 (0.33) ALDH1A1
SCHEMBL2205511 0.78 TLR4 (0.54) ALDH1A1HDAC6TLR4TLR2
SCHEMBL13400246 0.78 ALDH1A1 (0.40) ALDH1A1HDAC6MLYCDATMHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100093865-A1 SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093865-A1 SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ALDH1A2, MPST, CLN6 ALDH1A1 314/4885HDAC6 250/4885MLYCD 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.